Navigation Links
Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian Cancer Stem Cells
Date:7/27/2011

n to be significantly more potent than NV-128 in pre-clinical research studies. Marshall Edwards plans to complete the required pre-clinical studies of NV-344 to submit an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) by the first quarter of 2012.

"This study exemplifies the importance of our ongoing collaboration with Dr. Mor and his associates at Yale University as well as our continuing commitment to enhancing our pipeline of novel drug candidates," said Daniel P. Gold, Ph.D., President and Chief Executive Officer of Marshall Edwards. "We are excited about the progress we are making with both of our lead candidates, NV-143 and NV-344, and look forward to reporting on their clinical development in the months ahead."

About Marshall Edwards

Marshall Edwards, Inc. (Nasdaq: MSHL) is a San Diego-based oncology company focused on the clinical development of novel anti-cancer therapeutics. The Company's lead programs focus on two families of small molecules that result in the inhibition of tumor cell metabolism. The first and most advanced is a NADH oxidase inhibitor program that includes lead drug candidate NV-143. The second is a mitochondrial inhibitor program that includes lead candidate NV-344. The Company expects to initiate a Phase I clinical trial of intravenous NV-143 in September 2011, followed by randomized Phase II trials in combination with chemotherapy. For more information, please visit www.marshalledwardsinc.com.

Under U.S. law, a new drug cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe and effective for the intended use. Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Pr
'/>"/>

SOURCE Marshall Edwards, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Marshall Edwards Announces Presentation of New Data Showing Activity in Chemotherapy-Resistant Ovarian Cancer Cells
2. Marshall Edwards Receives NASDAQ Notice Of Non-Compliance; Intends To Request Hearing
3. Marshall Edwards to Host Annual Meeting of Stockholders
4. Marshall Edwards Receives Positive Response From NASDAQ
5. Marshall Edwards Announces Publication of Phase II Clinical Trial Results Highlighting Activity of Intravenous Phenoxodiol
6. Marshall Edwards Announces Private Placement
7. Marshall Edwards Announces Closing of Asset Purchase Agreement With Novogen
8. Marshall Edwards Announces Publication of Pre-Clinical Studies in Pancreatic Cancer
9. Edwards Resilient Trial Demonstrates Statistically Superior Results for Treating Peripheral Arterial Disease in the Leg
10. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
11. Medical Device Consultants, Inc. Welcomes Brian Edwards, Senior Regulatory Staff Consultant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 30, 2015   Millar, Inc. , a leader ... the 2016 retirement of Craig Thummel , President/CEO ... years of service to the Company. The Company also ... members of the Executive Management team as his successors. ... , currently Director of Sales and Marketing, as President, ...
(Date:6/30/2015)... VALLEY, Pa. , June 30, 2015 /PRNewswire/ ... and delivering innovative solutions for medical and surgical ... is guaranteeing next-day replacements for surgical equipment at ... product manufacturer to offer this type of guarantee. ... Olympus Full Service Agreement earlier this year. ...
(Date:6/30/2015)... Calif. , June 30, 2015  Ardelyx, Inc. ... on cardio-renal, gastrointestinal and metabolic diseases, today announced that ... July 14, 2015, from 8:00 a.m.- 1:00 pm EDT ... The Ardelyx senior management team will present ... lead compound, tenapanor, which has completed Phase 2b clinical ...
Breaking Medicine Technology:Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 2Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 3Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2
... The U.S. Food and Drug Administration is requiring ... on their labels about the risk of a ... systemic fibrosis (NSF), if the drug is administered ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo:   ...
... (Nasdaq: MSON ), a developer of ... which worldwide is used for acute health conditions, ... distribution agreement with Dismeval, s.l.,  based in Valencia, ... Ultrasonic Surgical Aspirator and the BoneScalpel™ Ultrasonic Bone ...
Cached Medicine Technology:FDA: New Warnings Required on Use of Gadolinium-Based Contrast Agents 2Misonix Announces New Distribution Agreement For Spain 2Misonix Announces New Distribution Agreement For Spain 3
(Date:6/30/2015)... ... June 30, 2015 , ... ... new video, “Grand Terrace Health Care Center.” Each year, Medicare ranks care centers ... find the best facility for their needs. Grand Terrace prides itself on quality ...
(Date:6/30/2015)... ... 2015 , ... According to a recent report by the U.S. Drug Enforcement ... than tripled in the same period—leading a majority of law enforcement agencies to cite ... leading Florida-based drug treatment facility, asserts that these heroin statistics point to an urgent ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... today that they have been awarded the exclusive billing agreements with Jackson Radiology ... of billing services encompassing their proprietary suite of billing process software functionality called ...
(Date:6/30/2015)... Angeles, CA (PRWEB) , ... June 30, 2015 , ... ... You Have Acne ,” listed five triggers that most people would not expect ... hair care products, and toothpaste. The primary causes of acne are clogged ...
(Date:6/30/2015)... ... 30, 2015 , ... Lakeview Health, a drug and alcohol ... of its medical staff to further enhance its ability to treat addiction patients ... and physician assistants -- now totals 17, compared to 7 in 2013, the ...
Breaking Medicine News(10 mins):Health News:Grand Terrace Health Care Center Announces Five-Star Rating in YouTube Video 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 4Health News:ADVOCATE Wins Billing Agreements with Jackson Radiology Associates 2Health News:A List of 5 Surprising Acne Triggers and the Latest Acne Treatment Options 2Health News:Lakeview Health, a Nationally Recognized Drug Rehabilitation Center in Florida, Doubles Size of Medical Staff 2
... quality of patient care using Microsoft technology.CHICAGO, April ... and Microsoft Corp. today announced the winners of ... For more than a decade, the honors have ... systems integrators that have demonstrated significant advancements, innovation ...
... and renowned Smoking Cessation Specialist Franc Tausch achieves record success rates ... session , ... Los Angeles, CA (PRWEB) August 15, ... Angeles, California enables smokers to stop smoking for life ...
... or Hispanic, report finds , , MONDAY, April 6 (HealthDay News) ... well known, but researchers have now produced an overview of ... intermittent or occasional smokers, which the U.S. Centers for ... smokers in the country, is published in a series of ...
... that modifies the androgen receptor (AR) and influences its ability ... cancer. The research, published by Cell Press in the April ... also drive creation of new strategies for the treatment of ... therapies. , The AR is an important mediator for ...
... first four in nation to receive accreditationGREEN BAY, ... Medical Center is one of the first four ... the National Accreditation Program for Breast Centers (NAPBC), ... the first breast program in Wisconsin to earn ...
... expanding nationally OKLAHOMA CITY, April 6 ... franchise to combine practical and spiritual assistance, is opening ... Cordova, Tenn. is scheduled to open on April 8, ... services outside of Oklahoma," said Tony Vann, vice president ...
Cached Medicine News:Health News:Microsoft and Microsoft Health Users Group Announce Winners of Microsoft HUG 2009 Innovation Awards 2Health News:Microsoft and Microsoft Health Users Group Announce Winners of Microsoft HUG 2009 Innovation Awards 3Health News:Microsoft and Microsoft Health Users Group Announce Winners of Microsoft HUG 2009 Innovation Awards 4Health News:Hypnotherapy Breakthrough: Renowned Smoking Cessation Specialist Helps To Stop Smoking In One Session 2Health News:Researchers Profile the 'Light' Smoker 2Health News:A potential new target for treatment of hormone refractory prostate cancer 2Health News:Aurora BayCare is Wisconsin's First Nationally Accredited Breast Program 2
... The Medtronic Subcutaneous Lead System ... subcutaneously with the use of ... 6996T. Improved SQ design and ... a fast and easy procedure, ...
The Livewire steerable electrophysiology catheter is uniquely designed with an ergonomic handle and patented steering mechanism to provide smooth, precise catheter tip movement, even during lengthy e...
... The Medtronic Sprint™ ... and the CapSureFix® Novus ... deliver superior electrical performance ... excellent sensing capabilities, low ...
... The SOLX DeepLight Glaucoma Treatment ... yet highly effective glaucoma treatments ... DeepLight Gold Micro-Shunt (GMS) and ... that help use the eye's ...
Medicine Products: